US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

25.37

-0.0975-0.38%

Post-market: 25.29-0.0763-0.30%16:10 EDT

Volume:860

Turnover:21.81K

Market Cap:5.83M

PE:- -

High:25.72

Open:25.72

Low:25.29

Close:25.46

52wk High:27.94

52wk Low:22.63

Shares:230.00K

Float Shares:230.00K

Volume Ratio:1.35

T/O Rate:0.37%

Dividend:0.41

Dividend Rate:1.63%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Retension Pharmaceuticals, TRex Bio File for US IPO as Biotech Momentum Continues

Sector Update: Healthcare

MT Newswires Live

Eli Lilly reports full FDA approval of Inluriyo combo for certain breast cancers

US FDA Approves Lilly Inluriyo-Verzenio Combo for ESR1-Mutated Metastatic Breast Cancer

U.S. FDA Approves Inluriyo (Imlunestrant) in Combination with Verzenio (Abemaciclib) for Adults with Er+, Her2-, Esr1-Mutated Advanced or Metastatic Breast Cancer

THOMSON REUTERS

Eli Lilly - Inluriyo with Verzenio NOW Available in the United States

THOMSON REUTERS

Novo Nordisk’s Once-Weekly Insulin Study Signals a New Phase for Diabetes Care

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

Novo Nordisk's Sogroya Gets Positive EU Opinion for Children With Idiopathic Short Stature

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN) and Axsome Therapeutics (AXSM)

All 50 States Sign up for Trump's Medicaid Most-Favored-Nation Plan

Sandoz Faces Uncertain Opportunity with New Drug Approval in Canada

Sandoz Receives Marketing Authorization for Generic Version of Ozempic in Canada

MT Newswires Live

When Weight Loss Isn't the Goal of Taking a GLP-1

Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day

Hims & Hers CTO Mohamed Elshenawy Sells 7,954 Shares Worth $225,421.06

Novo Nordisk Wins EMA Panel Backing for New Haemophilia A Therapy FREHEMGO

Novo Nordisk A/S Stock (NVO) Moved Up by 3.02% on Sep 17: What Signal Does It Send?

Cboe data suggests bullish flow in Novo Nordisk with shares up 3.3%

Novo Nordisk's Frehemgo to Treat Haemophilia A Receives CHMP Recommendation for EU Approval

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/THNR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"THNR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THNR\",,,,,undefined,":{"symbol":"THNR","market":"US","secType":"STK","nameCN":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","latestPrice":25.3662,"timestamp":1789761600000,"preClose":25.4637,"halted":0,"volume":860,"hourTrading":{"tag":"盘后","latestPrice":25.2899,"preClose":25.3662,"latestTime":"16:10 EDT","volume":6,"amount":152.1848,"timestamp":1789762204300,"change":-0.0763,"changeRate":-0.003008,"amplitude":0},"delay":0,"changeRate":-0.0038289800775221255,"floatShares":230000,"shares":230000,"eps":0,"marketStatus":"Closed","change":-0.0975,"latestTime":"09-18 16:00:00 EDT","open":25.72,"high":25.72,"low":25.2899,"amount":21809,"amplitude":0.016891,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":25.4637,"sharesOutstanding":170000,"nav":25.42,"aum":5846600,"dividendRate":0.016262,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":25.2899,"preClose":25.3662,"latestTime":"16:10 EDT","volume":6,"amount":152.1848,"timestamp":1789762204300,"change":-0.0763,"changeRate":-0.003008,"amplitude":0},"volumeRatio":1.345432},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THNR\",,,,,undefined,":{"symbol":"THNR","floatShares":230000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.345432,"shares":230000,"dividePrice":0.4125,"high":25.72,"amplitude":0.016891,"preClose":25.4637,"low":25.2899,"week52Low":22.6289,"pbRate":"--","week52High":27.94,"institutionHeld":0,"latestPrice":25.3662,"eps":0,"divideRate":0.016262,"volume":860,"delay":0,"ttmEps":0,"open":25.72,"prevYearClose":25.22,"prevWeekClose":25.59,"prevMonthClose":26.6886,"prevQuarterClose":25.6909,"fiveDayClose":25.59,"twentyDayClose":27.25,"sixtyDayClose":24.8756},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/THNR\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"THNR","amount":0.41317273,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2025-12-31"},{"date":"2024-12-30","symbol":"THNR","amount":0.219898,"announcedDate":"2024-12-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2024-12-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"THNR\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-30","recordDate":"2024-12-30","paymentDate":"2024-12-31","value":0.219898,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2025-12-31","value":0.41317273,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"THNR\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"THNR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668397655","title":"Retension Pharmaceuticals, TRex Bio File for US IPO as Biotech Momentum Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=2668397655","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668397655?lang=en_us&edition=fundamental","pubTime":"2026-09-19 06:26","pubTimestamp":1789770365,"startTime":"0","endTime":"0","summary":"Retension Pharmaceuticals, TRex Bio file for US IPO as biotech momentum continuesSept 18 (Reuters)-Drug developers Retension Pharmaceuticals and TRex Bio filed their paperwork for U.S. initial public ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL4N45A1OF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0353189763.USD","IHE","LU0786609619.USD","LU1280957306.USD","LU1917777945.USD","LU2237443549.SGD","LU1814569148.SGD","LU2237438978.USD","LU1035775433.USD","LU0471298694.HKD","CANC","SGXZ51526630.SGD","LU1023059063.AUD","LU0820562030.AUD","LU2756315318.SGD","LU2237443465.HKD","SG9999015978.USD","LU0820561909.HKD","LU2456880835.USD","SG9999015952.SGD","LU1548497426.USD","LU2491050154.USD","MHIP","LU1979441026.SGD","LU2236285917.USD","PPH","TRUH","LU0114720955.EUR","LU2028103732.USD","IE00BKPKM429.USD","SG9999013999.USD","LU0345770308.USD","LU2417539215.USD","LU0353189680.USD","IE00B4R5TH58.HKD","WDNA","LU0289739699.SGD","LU2265009873.SGD","IE00BJJMRZ35.SGD","LU0823434583.USD","LU1232071149.USD","LU2168563687.JPY","LU2552382215.SGD","GDOC","LU2023250330.USD","LU2213496289.HKD","LU2552382058.USD","LU2237443895.HKD","IE00B4JS1V06.HKD","SG9999018865.SGD","LU2361044949.HKD","LU0198837287.USD","LU1629891620.HKD","LU0466842654.USD","LU0234572021.USD","SG9999015986.USD","ETRA","LU0345770993.USD","LU0889565916.HKD","LU2360106947.USD","VHT","IE00B775H168.HKD","JDOC","LU2211815571.USD","LU0417517546.SGD","LU0683600562.USD","TMED","LU2324357040.USD","BK4086","LU2746668461.USD","LU1127390331.HKD","LU2168564065.EUR","LU0158827948.USD","LU2361044865.SGD","SG9999018857.SGD","LU2108987350.USD","LU2361045086.USD","LU2237443382.USD","LU0210536198.USD","LU0320765992.SGD","LU2168564149.EUR","OZEM","LU2357305700.SGD","LU1691799644.USD","LU1291159041.SGD","LU0097036916.USD","LU0820561818.USD","LU2237443622.USD","LU2271345857.HKD","BK4127","LU0094547139.USD","ELIS","LU0256863811.USD","LU0256863902.USD","FTXH","MEDI","TREX","LU0432979614.USD","IE0004445015.USD","LU0109394709.USD","LU2750360641.GBP","LU0323591593.USD","IE00BWXC8680.SGD","LU1069344957.HKD","IE00BK4W5M84.HKD","LU2750360997.AUD","LU0943347566.SGD","LU2461242641.AUD","LU2602419157.SGD","IE00BFTCPJ56.SGD","LU2491049909.HKD","LU0106261372.USD","IXJ","IE00B2B36J28.USD","SG9999001176.SGD","LU1623119135.USD","LU1720051108.HKD","LU0672654240.SGD","LU1145028129.USD","LU2462591350.SGD","LU2471134952.CNY","IE00B1XK9C88.USD","LU0354030511.USD","LU0823434740.USD","LU2089984988.USD","IYH","LU0096364046.USD","MEDX","SG9999014898.SGD","BK4534","LU1989771016.USD","LU2087625088.SGD","IE00B1BXHZ80.USD","LU2468319806.SGD","LU0006306889.USD","IE00BJLML261.HKD","LU0385154629.USD","LU0225283273.USD","LU2168564222.USD","LU1093756325.SGD","LU2112291526.USD","LU1323610961.USD","LU1720051017.SGD","LU2111349929.HKD","IE0004445239.USD","SG9999014906.USD","SGXZ31699556.SGD","LU2471134523.USD","EVR","LU0122379950.USD","LU1983299246.USD","LU1057294990.SGD","LU0058720904.USD","LU1868837300.USD","ELIL","LU0964807845.USD","LU0640476718.USD","LU2896262040.SGD","LU0238689110.USD","LU1868836757.USD","LU1061106388.HKD","RXL","LU1804176565.USD","HRTS","LU0061475181.USD","LU2023251221.USD","BK4007","BK4516","BK4588","IE0005OL40V9.USD","LU1868836914.USD","IE0001KFT4U8.USD","SGXZ99366536.SGD","LU0787776722.HKD","GB00BDT5M118.USD","LLY","CURE","SG9999001176.USD","IE00BJT1NW94.SGD","LU1267930730.SGD","LU1366192091.USD","LU1974910355.USD","IE00BJJMRY28.SGD","LU2237443978.SGD","LU0109391861.USD","LU0203201768.USD","IE00B7KXQ091.USD","LU0266013472.USD","LU2264538146.SGD","LU1064131342.USD","LU2089283258.USD","LU2471134879.HKD","SGXZ57979304.SGD","IE00BK4W5L77.USD","LU1093756168.USD","LU0158827781.USD","LU2089284900.SGD","SG9999015945.SGD","LU1988902786.USD","LU0823416689.USD","ILDR","LU2471134796.USD","LU1868836591.USD","LU1712237335.SGD","LLYX","FHLC","BK4599","AGNG","LU0320765059.SGD","LU0471298777.SGD","IE0002141913.USD","IE0009355771.USD","LU2023250504.SGD","LU2462157665.USD","LU2168564495.EUR","LU2756315664.SGD","LLYZ","SG9999014914.USD","BK4585","XLV","LU0354030438.USD","SG9999014880.SGD","SGXZ81514606.USD","LU2552382132.HKD","LU0133085943.USD","LU0708995401.HKD","LU1868837136.USD","BK4533","IE00BN29S564.USD","LU2746668974.SGD","LU0203202063.USD","LU0882574055.USD","LU2063271972.USD","LU1551013342.USD","LU0882574139.USD","LU0316494557.USD","IE00BFSS8Q28.SGD","PJP","LLII","LU0079474960.USD","LU0174119429.USD","THNR","LU1551013425.SGD","LU0689472784.USD","BK4581","IE00BKDWB100.SGD","LU2106854487.HKD","IE00BFSS7M15.SGD","LU2491050071.SGD","SG9999017495.SGD","LU0456855351.SGD","IE00BJJMRX11.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668978316","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2668978316","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668978316?lang=en_us&edition=fundamental","pubTime":"2026-09-19 03:38","pubTimestamp":1789760294,"startTime":"0","endTime":"0","summary":"Healthcare stocks were softer late Friday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF  each decreasing 0.2%The iShares Biotechnology ETF  fell 1.1%.In corporate news, Eli Lilly  said Friday that the US Food and Drug Administration has approved Inluriyo in combination with Verzenio for breast cancer. Lilly shares were fractionally higher.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0256863902.USD","LU0174119429.USD","BK4581","SG9999015945.SGD","ELIS","LLII","LU0683600562.USD","LU2236285917.USD","LU0820561818.USD","LU2237443382.USD","LU2491050071.SGD","GB00BDT5M118.USD","LU0316494557.USD","BK4585","LU2168564495.EUR","LU2456880835.USD","SG9999015978.USD","LU0256863811.USD","PJP","LU2896262040.SGD","LU1974910355.USD","SG9999018865.SGD","IE0002141913.USD","LU0234572021.USD","LU2750360641.GBP","XLV","LU1280957306.USD","IE00B4JS1V06.HKD","LU2756315664.SGD","SG9999015952.SGD","IE0004445015.USD","IHE","LU0689472784.USD","LU2552382132.HKD","LU2360106947.USD","LU1323610961.USD","LU2028103732.USD","LU1145028129.USD","LU0133085943.USD","LU0106261372.USD","VHT","LU1232071149.USD","LU1035775433.USD","LU0320765992.SGD","LU2237438978.USD","LU2552382058.USD","LU2237443549.SGD","LU1069344957.HKD","LU1551013342.USD","BK4534","MEDI","LU1691799644.USD","LU2213496289.HKD","LU0471298777.SGD","LU0109391861.USD","LU0820562030.AUD","LU2108987350.USD","LU0672654240.SGD","SG9999017495.SGD","IE00BJT1NW94.SGD","IBB","LU1720051108.HKD","IE00BK4W5M84.HKD","LU1093756325.SGD","LU1267930730.SGD","LU2087625088.SGD","TMED","LU0786609619.USD","TRUH","IE0009355771.USD","LU2357305700.SGD","IE00B4R5TH58.HKD","LU2471134952.CNY","LU2417539215.USD","SGXZ81514606.USD","LU1291159041.SGD","BK4533","IE0004445239.USD","LU2746668461.USD","SGXZ31699556.SGD","IE00BFTCPJ56.SGD","XBI","LU0061475181.USD","SGXZ99366536.SGD","IE00BJJMRY28.SGD","LU2168564065.EUR","LU2756315318.SGD","LLYZ","LU0203202063.USD","LU1868837300.USD","LU2089984988.USD","LU2168563687.JPY","LU0079474960.USD","SG9999014906.USD","LU1093756168.USD","LU2602419157.SGD","LU2471134523.USD","LU1868836757.USD","PPH","LU0456855351.SGD","LU1712237335.SGD","LU2491049909.HKD","LU2471134796.USD","THNR","IE00B7KXQ091.USD","LU0823416689.USD","LU2552382215.SGD","SG9999013999.USD","LU2089284900.SGD","LU1629891620.HKD","LU2023250330.USD","GDOC","LU2023251221.USD","SG9999014880.SGD","LU0385154629.USD","LU1989771016.USD","IE00BJJMRZ35.SGD","LU0466842654.USD","ELIL","LU1868837136.USD","IE00BFSS8Q28.SGD","LU0787776722.HKD","LU1814569148.SGD","LU2491050154.USD","LU0158827781.USD","LU0210536198.USD","IE00BKPKM429.USD","LU0320765059.SGD","LU2750360997.AUD","LU1983299246.USD","IYH","LU0353189763.USD","LU1064131342.USD","AGNG","SGXZ57979304.SGD","LU2468319806.SGD","LU1917777945.USD","LU0158827948.USD","MHIP","LU0203201768.USD","BK4516","LU2168564149.EUR","LU0640476718.USD","LU0943347566.SGD","LU0820561909.HKD","LU2111349929.HKD","LU0889565916.HKD","LU0006306889.USD","LU1127390331.HKD","LU2461242641.AUD","LU2324357040.USD","LU1979441026.SGD","LU2063271972.USD","IE00BJLML261.HKD","RXL","BK4588","IE00BWXC8680.SGD","LU0345770993.USD","LU2237443465.HKD","LU1023059063.AUD","LU2089283258.USD","LABU","LLY","LU0198837287.USD","LU2462157665.USD","SG9999001176.SGD","BK4599","IE00BN29S564.USD","LU0289739699.SGD","LU1988902786.USD","LU0058720904.USD","LU0225283273.USD","LU0882574055.USD","SG9999015986.USD","LU0114720955.EUR","LU0238689110.USD","LU2237443978.SGD","LU2471134879.HKD","LU0823434740.USD","IE0005OL40V9.USD","LU2211815571.USD","LU0122379950.USD","LU2237443622.USD","FHLC","MEDX","IE00BJJMRX11.SGD","IE00BFSS7M15.SGD","LU2237443895.HKD","LU1366192091.USD","BK4007","LLYX","CANC","LU0266013472.USD","LU0345770308.USD","LU2462591350.SGD","LU1720051017.SGD","LU0417517546.SGD","LU2112291526.USD","LU2271345857.HKD","OZEM","LU0823434583.USD","LU1868836914.USD","LU2361045086.USD","LU2746668974.SGD","SG9999014898.SGD","LU0094547139.USD","LU1551013425.SGD","IXJ","WDNA","LU0354030438.USD","CURE","LU2023250504.SGD","ILDR","LU0471298694.HKD","LU1057294990.SGD","IE00B2B36J28.USD","SGXZ51526630.SGD","LU0109394709.USD","IE00BKDWB100.SGD","LU0432979614.USD","IE00B1BXHZ80.USD","LU2264538146.SGD","IE00BK4W5L77.USD","LU0882574139.USD","LU1804176565.USD","SG9999001176.USD","SG9999014914.USD","LU2361044949.HKD","LU0097036916.USD","LU2361044865.SGD","LU1868836591.USD","LU0096364046.USD","FTXH","SG9999018857.SGD","JDOC","LU2265009873.SGD","HRTS","LU0323591593.USD","LU1623119135.USD","IE0001KFT4U8.USD","LU0354030511.USD","LU1061106388.HKD","LU0708995401.HKD","LU1548497426.USD","LU2106854487.HKD","LU2168564222.USD","LU0353189680.USD","LU0964807845.USD","IE00B1XK9C88.USD","IE00B775H168.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668292056","title":"Eli Lilly reports full FDA approval of Inluriyo combo for certain breast cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2668292056","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668292056?lang=en_us&edition=fundamental","pubTime":"2026-09-19 02:00","pubTimestamp":1789754413,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY) announced that the U.S. Food and Drug Administration has granted full approval to Inluriyo, an oral estrogen receptor antagonist, i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eli-lilly-reports-full-fda-approval-of-inluriyo-combo-for-certain-breast-cancers-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eli-lilly-reports-full-fda-approval-of-inluriyo-combo-for-certain-breast-cancers-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","LLYZ","LU2462591350.SGD","IE00BFSS7M15.SGD","LU0354030438.USD","LU1023059063.AUD","LU2461242641.AUD","LU2756315664.SGD","LU1551013342.USD","SG9999018857.SGD","LU1323610961.USD","BK4533","LU1064131342.USD","LU0943347566.SGD","TMED","IE0002141913.USD","LU1868836591.USD","LU2361044865.SGD","LU1093756325.SGD","LU2237438978.USD","LU0109394709.USD","OZEM","LU2471134796.USD","LU2168563687.JPY","LU2168564149.EUR","LU0323591593.USD","ILDR","LU0097036916.USD","IE00BFSS8Q28.SGD","LU0786609619.USD","LU0787776722.HKD","IE00BJLML261.HKD","LU0417517546.SGD","BK4534","LU0432979614.USD","LU0672654240.SGD","LU0820562030.AUD","LU2168564222.USD","SG9999014898.SGD","LU1712237335.SGD","LU1720051017.SGD","CURE","LU2213496289.HKD","LU0006306889.USD","LU2089284900.SGD","LU1804176565.USD","LU2108987350.USD","LU2491050071.SGD","LU0158827781.USD","SG9999001176.USD","LU1035775433.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU2168564065.EUR","SG9999013999.USD","LU0289739699.SGD","LU0708995401.HKD","LU2237443465.HKD","LU0353189763.USD","IE00B775H168.HKD","LU1291159041.SGD","IE0009355771.USD","LU2462157665.USD","ELIL","LU0198837287.USD","IE00BN29S564.USD","LU0094547139.USD","LU0823434740.USD","LU0354030511.USD","LU1061106388.HKD","LU2471134952.CNY","LU2063271972.USD","IE00BKPKM429.USD","LU2211815571.USD","LU2552382215.SGD","BK4007","LU1917777945.USD","LU0820561909.HKD","LU2237443622.USD","LU2089984988.USD","THNR","SG9999014906.USD","LU1093756168.USD","SGXZ31699556.SGD","XLV","LU2237443382.USD","LU2023250330.USD","LU2756315318.SGD","IE00B1XK9C88.USD","LU1145028129.USD","LU1983299246.USD","IE00B2B36J28.USD","LU2089283258.USD","LU0823416689.USD","LU2746668974.SGD","LU0058720904.USD","LU0882574139.USD","LU2271345857.HKD","RXL","SG9999015945.SGD","JDOC","LU2087625088.SGD","LU2237443978.SGD","IXJ","LU0061475181.USD","LU0689472784.USD","LU1267930730.SGD","LU1814569148.SGD","IE00BJJMRX11.SGD","LU0225283273.USD","IE00B4JS1V06.HKD","BK4588","LU2360106947.USD","LU2236285917.USD","LU2361044949.HKD","LU0316494557.USD","LU0320765992.SGD","BK4599","LU0820561818.USD","LU0238689110.USD","LU2106854487.HKD","LU0096364046.USD","LU0210536198.USD","LU0466842654.USD","IE0004445015.USD","LU0158827948.USD","IE00B7KXQ091.USD","LU2746668461.USD","SGXZ57979304.SGD","LU1691799644.USD","LU0256863902.USD","PJP","LU1232071149.USD","IE0005OL40V9.USD","IE00BJJMRY28.SGD","SG9999015978.USD","LU2417539215.USD","LU0122379950.USD","LU0114720955.EUR","LU2456880835.USD","HRTS","LU1974910355.USD","LU2028103732.USD","MEDX","IE00BK4W5M84.HKD","LU2602419157.SGD","VHT","LU0889565916.HKD","LU1069344957.HKD","LU2471134879.HKD","LU2361045086.USD","IE00BWXC8680.SGD","LU2023251221.USD","SG9999015952.SGD","MHIP","TRUH","SG9999001176.SGD","LU1988902786.USD","CANC","SG9999017495.SGD","LLII","LU1127390331.HKD","LU0203201768.USD","BK4516","LU2471134523.USD","IE00B1BXHZ80.USD","LU1280957306.USD","LLYX","LU0106261372.USD","LU1548497426.USD","LU0882574055.USD","LU0385154629.USD","LU1057294990.SGD","LU0823434583.USD","LU1720051108.HKD","FTXH","LU1989771016.USD","FHLC","LU1366192091.USD","ELIS","LU2491050154.USD","LU0640476718.USD","LU0203202063.USD","LU0471298694.HKD","LU1629891620.HKD","LU1868836757.USD","LU1868837136.USD","LU2111349929.HKD","LU0109391861.USD","LU0471298777.SGD","LU1623119135.USD","LU2552382058.USD","LU2750360641.GBP","LU0133085943.USD","LU2023250504.SGD","IE0004445239.USD","LU0353189680.USD","LU2264538146.SGD","LU2552382132.HKD","IE00BFTCPJ56.SGD","SGXZ81514606.USD","AGNG","LU2237443895.HKD","LU0234572021.USD","LU1868837300.USD","LU2750360997.AUD","LU2324357040.USD","SG9999014914.USD","LU0456855351.SGD","WDNA","LLY","LU1868836914.USD","LU2112291526.USD","LU0964807845.USD","LU2265009873.SGD","PPH","LU0266013472.USD","LU2896262040.SGD","SG9999018865.SGD","LU2237443549.SGD","IE00BK4W5L77.USD","LU0174119429.USD","LU2168564495.EUR","LU2468319806.SGD","LU1979441026.SGD","IHE","SG9999015986.USD","IE00BKDWB100.SGD","IE00BJJMRZ35.SGD","LU0683600562.USD","LU0345770308.USD","SGXZ51526630.SGD","SGXZ99366536.SGD","LU0079474960.USD","SG9999014880.SGD","GB00BDT5M118.USD","LU0320765059.SGD","LU1551013425.SGD","LU0345770993.USD","LU0256863811.USD","IE0001KFT4U8.USD","LU2491049909.HKD","LU2357305700.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668092703","title":"US FDA Approves Lilly Inluriyo-Verzenio Combo for ESR1-Mutated Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2668092703","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668092703?lang=en_us&edition=fundamental","pubTime":"2026-09-19 01:55","pubTimestamp":1789754125,"startTime":"0","endTime":"0","summary":"US FDA approves Lilly Inluriyo-Verzenio combo for ESR1-mutated metastatic breast cancerFDA granted full approval for Inluriyo (imlunestrant) with Verzenio (abemaciclib) in ESR1-mutated ER+, HER2- adva","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL8WZwyr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","LU2750360997.AUD","SG9999014906.USD","LU0354030511.USD","LU0417517546.SGD","LU0353189680.USD","LU0354030438.USD","LU0320765059.SGD","LU2237438978.USD","BK4516","LU0238689110.USD","LU0096364046.USD","LU2089283258.USD","SGXZ81514606.USD","LU2087625088.SGD","RXL","JDOC","LU1280957306.USD","IE00B775H168.HKD","MEDI","LU1720051108.HKD","LU0823416689.USD","LU2168564065.EUR","PJP","IE00B7KXQ091.USD","LU1974910355.USD","IE0009355771.USD","LU1093756325.SGD","SGXZ57979304.SGD","SG9999014880.SGD","LLII","LU1804176565.USD","LU2236285917.USD","LU0964807845.USD","LU0289739699.SGD","LU1868836914.USD","LU0094547139.USD","LU1323610961.USD","LU1057294990.SGD","LU2237443382.USD","IE00BJLML261.HKD","BK4585","CURE","LU2168564222.USD","IE00BWXC8680.SGD","LU2746668974.SGD","LU0158827781.USD","LU1989771016.USD","BK4007","LU1232071149.USD","IE00BKPKM429.USD","LU1814569148.SGD","SG9999018857.SGD","LU0823434583.USD","LU2211815571.USD","SG9999017495.SGD","IE00BJJMRZ35.SGD","TRUH","IE00B2B36J28.USD","TMED","LU2265009873.SGD","LU0266013472.USD","LU1868837136.USD","LU0174119429.USD","LU0820561909.HKD","LU1061106388.HKD","LU1064131342.USD","LU0345770308.USD","SG9999018865.SGD","IE00BN29S564.USD","LU0432979614.USD","SG9999013999.USD","LU1069344957.HKD","LU2023251221.USD","LU0889565916.HKD","LU2112291526.USD","SGXZ51526630.SGD","LU2471134796.USD","LU0061475181.USD","LU2468319806.SGD","LU2602419157.SGD","SG9999014914.USD","IE00BFSS8Q28.SGD","THNR","FHLC","LU1720051017.SGD","XLV","LU2756315664.SGD","LU2360106947.USD","LU0256863811.USD","SG9999015978.USD","SGXZ99366536.SGD","LU1868837300.USD","LU0708995401.HKD","LU2756315318.SGD","LU2237443465.HKD","IE00B4JS1V06.HKD","LU1691799644.USD","LU2108987350.USD","LU0882574139.USD","BK4588","LU2361044949.HKD","LU0683600562.USD","LU0323591593.USD","LU1623119135.USD","LU2750360641.GBP","IE0005OL40V9.USD","IHE","LU2089984988.USD","LU2111349929.HKD","LU0787776722.HKD","LU2462591350.SGD","LU0106261372.USD","LU0320765992.SGD","LU2271345857.HKD","OZEM","LU2552382215.SGD","LU2237443549.SGD","LU0234572021.USD","LU0109394709.USD","LU0471298694.HKD","IE00BK4W5M84.HKD","LU2063271972.USD","LU2106854487.HKD","IE0001KFT4U8.USD","IE00BJJMRY28.SGD","LU0456855351.SGD","LU2357305700.SGD","LU2471134952.CNY","LU1988902786.USD","LU1983299246.USD","BK4533","IE00BJT1NW94.SGD","IE00B1XK9C88.USD","LU0345770993.USD","LU1127390331.HKD","SG9999014898.SGD","IE00BK4W5L77.USD","IE00BFSS7M15.SGD","IYH","ELIL","LU2237443895.HKD","LU1035775433.USD","LU1267930730.SGD","LU1712237335.SGD","LU0823434740.USD","LU2417539215.USD","SG9999001176.USD","IE00BKDWB100.SGD","LU0466842654.USD","LU0114720955.EUR","LU2456880835.USD","LU0256863902.USD","LU0943347566.SGD","LU2089284900.SGD","LU2746668461.USD","LU2471134879.HKD","LU2896262040.SGD","LU0097036916.USD","LU2552382058.USD","LU1917777945.USD","SG9999015986.USD","LU1868836757.USD","IE00B4R5TH58.HKD","LU0198837287.USD","LU1551013342.USD","LU2264538146.SGD","LU0079474960.USD","IE00B1BXHZ80.USD","LU0353189763.USD","LU0203201768.USD","LU1093756168.USD","LU2462157665.USD","BK4534","LU2023250504.SGD","HRTS","BK4599","SGXZ31699556.SGD","LU2168563687.JPY","MHIP","ELIS","LU0006306889.USD","LU0158827948.USD","LU0122379950.USD","LU0640476718.USD","LU1145028129.USD","LU2361044865.SGD","LU2471134523.USD","LU2552382132.HKD","LU0385154629.USD","MEDX","LU0820561818.USD","IE0004445239.USD","LU0316494557.USD","LU0109391861.USD","LU2023250330.USD","SG9999001176.SGD","LU0210536198.USD","LU2324357040.USD","LU0225283273.USD","LLY","LU2237443622.USD","BK4581","LU2491050154.USD","VHT","LU0689472784.USD","LU1366192091.USD","IE00BFTCPJ56.SGD","IE0004445015.USD","LU2491049909.HKD","LU2213496289.HKD","LLYZ","LU2491050071.SGD","LU0820562030.AUD","LLYX","LU1548497426.USD","LU2168564495.EUR","PPH","SG9999015945.SGD","IXJ","LU1551013425.SGD","ILDR","LU0133085943.USD","LU0672654240.SGD","LU2361045086.USD","IE0002141913.USD","LU2028103732.USD","LU0786609619.USD","GDOC","LU2461242641.AUD","SG9999015952.SGD","LU2237443978.SGD","WDNA","LU1629891620.HKD","LU1868836591.USD","LU1291159041.SGD","FTXH","IE00BJJMRX11.SGD","LU0203202063.USD","LU0471298777.SGD","LU1979441026.SGD","LU1023059063.AUD","LU0058720904.USD","CANC","LU2168564149.EUR","GB00BDT5M118.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668927039","title":"U.S. FDA Approves Inluriyo (Imlunestrant) in Combination with Verzenio (Abemaciclib) for Adults with Er+, Her2-, Esr1-Mutated Advanced or Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2668927039","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668927039?lang=en_us&edition=fundamental","pubTime":"2026-09-19 01:54","pubTimestamp":1789754067,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nTUA7B3KKM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IHE","LU2265009873.SGD","LU2211815571.USD","LU0097036916.USD","LU0158827948.USD","LU1623119135.USD","LU2237443382.USD","BK4585","ELIS","LU1917777945.USD","LU2023250330.USD","LU0114720955.EUR","IE00B1BXHZ80.USD","LU0786609619.USD","LU0354030438.USD","TRUH","LU0708995401.HKD","MHIP","IE00BFTCPJ56.SGD","ELIL","LU0882574055.USD","LU0323591593.USD","LU2106854487.HKD","LU2491050071.SGD","LU2756315318.SGD","LU2063271972.USD","THNR","LU1127390331.HKD","WDNA","LU1057294990.SGD","LU2168564065.EUR","LU2112291526.USD","LU0106261372.USD","IE00B775H168.HKD","LU1629891620.HKD","SGXZ99366536.SGD","LU2491049909.HKD","BK4534","CANC","BK4007","IE00B4R5TH58.HKD","IE00BFSS8Q28.SGD","LU0234572021.USD","LU0823434583.USD","BK4581","SG9999018865.SGD","LU0354030511.USD","LU1551013425.SGD","LU1868836757.USD","RXL","LU1868837300.USD","LU0079474960.USD","LU2361045086.USD","LU0943347566.SGD","LU0683600562.USD","LU2746668974.SGD","SG9999017495.SGD","LU2471134523.USD","IE0005OL40V9.USD","SGXZ57979304.SGD","LU2468319806.SGD","FTXH","IE00BK4W5L77.USD","SG9999013999.USD","LU2471134796.USD","LU0689472784.USD","LU0353189763.USD","LU2237443549.SGD","LU1035775433.USD","LU0640476718.USD","LU2552382132.HKD","IE0004445239.USD","SGXZ51526630.SGD","LU0238689110.USD","FHLC","LU0823416689.USD","IE00BKPKM429.USD","LU2361044865.SGD","LU0672654240.SGD","LU0158827781.USD","IE0002141913.USD","IE00BJJMRX11.SGD","XLV","LU1868837136.USD","LU0820561818.USD","IYH","LU2168564222.USD","LU0964807845.USD","GB00BDT5M118.USD","HRTS","LU2896262040.SGD","LU0820561909.HKD","LU0198837287.USD","LU0345770993.USD","LLII","IE0009355771.USD","LU2108987350.USD","LU1983299246.USD","LU1267930730.SGD","LU0266013472.USD","GDOC","LU0109391861.USD","LU2111349929.HKD","LU2461242641.AUD","LU0289739699.SGD","IE00BJLML261.HKD","SGXZ81514606.USD","SG9999014906.USD","LU2750360641.GBP","SG9999015952.SGD","LU0094547139.USD","LU2357305700.SGD","LU0316494557.USD","IE00BKDWB100.SGD","LU1868836914.USD","LU2237443465.HKD","LU0823434740.USD","LU1974910355.USD","LU0122379950.USD","LU0320765992.SGD","LU2023250504.SGD","LU1988902786.USD","LU2324357040.USD","VHT","AGNG","LU2271345857.HKD","LU2456880835.USD","LU2237438978.USD","ILDR","LU2028103732.USD","LU2089284900.SGD","IE00BJJMRZ35.SGD","LU1069344957.HKD","LU2756315664.SGD","IXJ","LU2236285917.USD","SG9999015978.USD","LU2168564149.EUR","LU2552382058.USD","LU1720051108.HKD","LU0133085943.USD","LU1093756325.SGD","IE00B7KXQ091.USD","LU0471298694.HKD","LU2168564495.EUR","LU0385154629.USD","IE00B1XK9C88.USD","LU2264538146.SGD","LU0882574139.USD","LU2361044949.HKD","LU2471134879.HKD","LU1323610961.USD","SG9999001176.USD","SGXZ31699556.SGD","LU1145028129.USD","LU2750360997.AUD","LU0820562030.AUD","LU2089984988.USD","IE00BJT1NW94.SGD","MEDI","LU1291159041.SGD","LU1868836591.USD","IE00B2B36J28.USD","LU1061106388.HKD","LU1366192091.USD","IE00BWXC8680.SGD","LU2462591350.SGD","LU2491050154.USD","LU0345770308.USD","LU0058720904.USD","LLYZ","LU0210536198.USD","LU0353189680.USD","LLY","LU1814569148.SGD","LU1023059063.AUD","LU0203202063.USD","LLYX","LU2746668461.USD","LU0432979614.USD","LU1712237335.SGD","LU0787776722.HKD","SG9999014898.SGD","LU1804176565.USD","LU2417539215.USD","SG9999015945.SGD","SG9999018857.SGD","IE0001KFT4U8.USD","CURE","LU0225283273.USD","SG9999014880.SGD","BK4516","LU0256863811.USD","SG9999014914.USD","LU0174119429.USD","LU2213496289.HKD","LU2168563687.JPY","BK4533","LU1551013342.USD","IE00BJJMRY28.SGD","LU1548497426.USD","LU0061475181.USD","LU1691799644.USD","LU0203201768.USD","MEDX","OZEM","LU2360106947.USD","LU0456855351.SGD","LU1064131342.USD","LU0466842654.USD","IE00BFSS7M15.SGD","LU1720051017.SGD","LU2237443622.USD","BK4599","SG9999001176.SGD","LU2089283258.USD","LU2023251221.USD","LU2552382215.SGD","BK4588","IE00BK4W5M84.HKD","PPH","PJP","LU0006306889.USD","IE00B4JS1V06.HKD","SG9999015986.USD","LU1093756168.USD","IE0004445015.USD","LU2237443895.HKD","LU0109394709.USD","LU2462157665.USD","JDOC","LU0417517546.SGD","LU2471134952.CNY","LU2087625088.SGD","LU2602419157.SGD","LU2237443978.SGD","TMED","LU0256863902.USD","LU1280957306.USD","LU1979441026.SGD","LU1232071149.USD","LU1989771016.USD","IE00BN29S564.USD","LU0889565916.HKD","LU0096364046.USD","LU0320765059.SGD","LU0471298777.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668692703","title":"Eli Lilly - Inluriyo with Verzenio NOW Available in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2668692703","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668692703?lang=en_us&edition=fundamental","pubTime":"2026-09-19 01:54","pubTimestamp":1789754067,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nTUA7B3KKM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0820562030.AUD","LU0097036916.USD","LU0256863902.USD","LU2750360641.GBP","LU0079474960.USD","LU1868836914.USD","IE00B7KXQ091.USD","LU1069344957.HKD","LU2168563687.JPY","LU0109394709.USD","IE00BK4W5L77.USD","LU2087625088.SGD","LU2468319806.SGD","LU0320765992.SGD","LU1551013342.USD","SG9999018857.SGD","TRUH","LU2552382058.USD","IE00BWXC8680.SGD","JDOC","LU0820561909.HKD","LU0432979614.USD","LU2028103732.USD","LU0354030438.USD","LU0689472784.USD","LU2462591350.SGD","OZEM","LU0225283273.USD","LU0320765059.SGD","LLII","LU0198837287.USD","LU1623119135.USD","GDOC","LU0266013472.USD","LU2491050154.USD","MEDX","LU0345770308.USD","IE00BJJMRZ35.SGD","LU0823434740.USD","LU2417539215.USD","PJP","LU1035775433.USD","LU0471298694.HKD","IE00BFTCPJ56.SGD","LU0114720955.EUR","LU0061475181.USD","LU0234572021.USD","LU0640476718.USD","IE00BJT1NW94.SGD","LU2106854487.HKD","RXL","LU2456880835.USD","LU0203201768.USD","LU1023059063.AUD","LU2552382132.HKD","LU2461242641.AUD","LU2746668974.SGD","LU0786609619.USD","LU2896262040.SGD","LU0353189680.USD","IE00BK4W5M84.HKD","HRTS","LU0106261372.USD","SG9999015978.USD","LU0943347566.SGD","LU0133085943.USD","MHIP","LU1064131342.USD","LU0210536198.USD","LU1814569148.SGD","LU2237443382.USD","LU2265009873.SGD","LU1691799644.USD","LU2089283258.USD","BK4516","IE00B775H168.HKD","SGXZ31699556.SGD","SG9999001176.SGD","LU2237443895.HKD","LU0354030511.USD","LU1629891620.HKD","IE0002141913.USD","LU2236285917.USD","TMED","LU0345770993.USD","LU1093756168.USD","LU0158827781.USD","LU1868837300.USD","LU1979441026.SGD","SG9999015952.SGD","LU2360106947.USD","SG9999001176.USD","SG9999018865.SGD","LU0174119429.USD","IE00BJJMRX11.SGD","IE00BN29S564.USD","LU0882574139.USD","CURE","LU1127390331.HKD","SGXZ51526630.SGD","LU1267930730.SGD","SG9999013999.USD","BK4534","IE0005OL40V9.USD","LU2271345857.HKD","SG9999015945.SGD","LU0203202063.USD","LU2237438978.USD","LU2023250504.SGD","LU1983299246.USD","BK4581","SG9999014914.USD","SGXZ99366536.SGD","IE0001KFT4U8.USD","LU0385154629.USD","WDNA","LU2361044865.SGD","LU0256863811.USD","IHE","LU1868836757.USD","IE00BKPKM429.USD","LU2491049909.HKD","CANC","LU1868837136.USD","LU0823416689.USD","IE00B4JS1V06.HKD","IE00B1BXHZ80.USD","LU2023251221.USD","LU2324357040.USD","LU2361044949.HKD","LU1804176565.USD","IE00BJLML261.HKD","SGXZ81514606.USD","LU0289739699.SGD","LU0672654240.SGD","IE00BKDWB100.SGD","LU2168564222.USD","LU2168564495.EUR","LU1551013425.SGD","LU2089984988.USD","FTXH","IE0004445239.USD","BK4007","LU2471134879.HKD","LLY","LU1280957306.USD","IE00BJJMRY28.SGD","LU2264538146.SGD","FHLC","PPH","LU1720051108.HKD","IXJ","LU0964807845.USD","LU0109391861.USD","BK4588","LU0158827948.USD","LU2112291526.USD","LU1323610961.USD","LU2491050071.SGD","LLYX","LU0122379950.USD","LU1232071149.USD","LU1868836591.USD","LU1093756325.SGD","MEDI","ELIL","LU0787776722.HKD","LU0889565916.HKD","LU1291159041.SGD","LU0096364046.USD","LU2089284900.SGD","LU2750360997.AUD","LU0820561818.USD","LU0708995401.HKD","THNR","LU2471134796.USD","IE00B2B36J28.USD","IYH","LU1988902786.USD","LLYZ","LU1917777945.USD","LU0683600562.USD","LU1061106388.HKD","SG9999014880.SGD","LU2237443978.SGD","LU2211815571.USD","IE0004445015.USD","XLV","BK4599","SG9999014898.SGD","LU0882574055.USD","GB00BDT5M118.USD","LU0466842654.USD","LU2471134952.CNY","LU0058720904.USD","LU1548497426.USD","LU1974910355.USD","IE00BFSS7M15.SGD","LU2108987350.USD","SG9999017495.SGD","IE00BFSS8Q28.SGD","LU0823434583.USD","LU1366192091.USD","LU0471298777.SGD","LU2756315664.SGD","LU1720051017.SGD","LU2237443622.USD","LU2462157665.USD","LU2357305700.SGD","VHT","LU2213496289.HKD","LU1989771016.USD","LU2237443465.HKD","LU2168564149.EUR","LU1057294990.SGD","LU0353189763.USD","LU0238689110.USD","LU2023250330.USD","LU0456855351.SGD","LU0323591593.USD","LU2746668461.USD","IE0009355771.USD","LU1712237335.SGD","SG9999014906.USD","LU2602419157.SGD","LU0417517546.SGD","LU2552382215.SGD","LU2756315318.SGD","LU2111349929.HKD","SGXZ57979304.SGD","SG9999015986.USD","LU2063271972.USD","BK4585","LU2471134523.USD","LU2361045086.USD","AGNG","LU1145028129.USD","ILDR","BK4533","LU2168564065.EUR","LU2237443549.SGD","LU0006306889.USD","LU0316494557.USD","ELIS","IE00B1XK9C88.USD","LU0094547139.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668092736","title":"Novo Nordisk’s Once-Weekly Insulin Study Signals a New Phase for Diabetes Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2668092736","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668092736?lang=en_us&edition=fundamental","pubTime":"2026-09-19 00:31","pubTimestamp":1789749071,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. This new Novo Nordisk study, officially titled “A Real-world, Multi-centre...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisks-once-weekly-insulin-study-signals-a-new-phase-for-diabetes-care?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisks-once-weekly-insulin-study-signals-a-new-phase-for-diabetes-care?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","THNR","LU1093756168.USD","LU1093756325.SGD","NVOH","BK4585","PPH","LU0154236417.USD","NVOX","NVOC","BK4532","NVO","IE00BZ1G4Q59.USD","BK4007","OZEM","BK4599","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668174922","title":"Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2668174922","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668174922?lang=en_us&edition=fundamental","pubTime":"2026-09-19 00:02","pubTimestamp":1789747320,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B rose 0.8% to DKK281.55 Friday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 0.7% to 2,654.97.This was the stock's second consecutive day of gains.The company closed DKK128.40 below its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 9,279,685, compared to the 50-day average trading volume of 4,148,734.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","IE00BZ1G4Q59.USD","NVO","PPH","0QIU.UK","NVOH","BK4532","LU0154236417.USD","IE00BKVL7J92.USD","BK5011","OZEM","BK4007","THNR","NVOX","LU1093756325.SGD","BK4588","NVOC","LU1093756168.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668014928","title":"Novo Nordisk's Sogroya Gets Positive EU Opinion for Children With Idiopathic Short Stature","url":"https://stock-news.laohu8.com/highlight/detail?id=2668014928","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668014928?lang=en_us&edition=fundamental","pubTime":"2026-09-18 19:47","pubTimestamp":1789732031,"startTime":"0","endTime":"0","summary":"Novo Nordisk  said Friday the European Medicines Agency's CHMP recommended once-weekly Sogroya for children with idiopathic short stature and persistent growth disturbance.If approved by the European Commission, Sogroya would become the first and only growth hormone treatment approved for idiopathic short stature in the EU, the company said.The recommendation follows earlier CHMP support for Sogroya in children born small for gestational age and those with Noonan syndrome, it added.The European Commission's decision on marketing authorization covering all three indications is expected later this year, Novo Nordisk said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVOX","OZEM","IE00BKVL7J92.USD","LU1093756325.SGD","BK4007","NVOH","PPH","BK4532","THNR","BK4599","BK4585","BK4588","LU1093756168.USD","IE00BZ1G4Q59.USD","LU0154236417.USD","NVOC","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668492827","title":"Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN) and Axsome Therapeutics (AXSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668492827","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668492827?lang=en_us&edition=fundamental","pubTime":"2026-09-18 19:30","pubTimestamp":1789731047,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN)...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eli-lilly-co-lly-biomarin-pharmaceutical-bmrn-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eli-lilly-co-lly-biomarin-pharmaceutical-bmrn-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2461242641.AUD","LU0158827948.USD","LLYX","BK4139","LU0820561818.USD","LU0174119429.USD","IE0004445015.USD","LU0466842654.USD","LU0640476718.USD","LU0456855351.SGD","LU0889565916.HKD","BK4599","LU2023251221.USD","LLY","LU2168564149.EUR","IE0002270589.USD","FHLC","LU0432979614.USD","LU0943347566.SGD","SG9999014880.SGD","IE00B2B36J28.USD","LU2237443549.SGD","PPH","TRUH","LU0345770993.USD","LU0823416689.USD","LU2756315318.SGD","LU2361045086.USD","LU0256863811.USD","LU2111349929.HKD","SG9999014914.USD","LU2491050154.USD","SG9999015978.USD","LU1868837300.USD","LU2471134523.USD","LU1868837136.USD","BK4566","LU2471134952.CNY","BK4516","ILDR","LU0097036916.USD","LU0823434583.USD","LU0353189763.USD","SG9999018857.SGD","WDNA","LU1093756325.SGD","BK4588","SGXZ99366536.SGD","LU2087625088.SGD","LU0471298777.SGD","LU2023250504.SGD","SG9999017495.SGD","LU2417539215.USD","LU0256863902.USD","LU1974910355.USD","IE00BFSS7M15.SGD","BK4585","LU2756315664.SGD","LU1814569148.SGD","LU2456880835.USD","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU0689472784.USD","FTXH","LU2602419157.SGD","MHIP","LU2896262040.SGD","IE00B775H168.HKD","LU0683600562.USD","LU2750360641.GBP","LU2264538146.SGD","BK4581","LU2028103732.USD","IE00B7SZLL34.SGD","LU2491050071.SGD","LU0096364046.USD","LU1804176565.USD","LU0353189680.USD","TMED","IE00B7KXQ091.USD","CANC","LU0006306889.USD","SG9999001176.SGD","IE0009355771.USD","LU1720051108.HKD","LU1989771016.USD","LU1035775433.USD","LU2237443382.USD","MEDI","LU0109394709.USD","LU1267930730.SGD","CURE","LU2552382215.SGD","LU0133085943.USD","IE00B19Z3581.USD","LU2168564495.EUR","LU2361044865.SGD","LU2468319806.SGD","LU1983299246.USD","LU2471134879.HKD","IE0002141913.USD","BK4505","LU2361044949.HKD","VHT","LU2491049909.HKD","LU0203201768.USD","MEDX","SG9999013999.USD","LU1551013425.SGD","LU1366192091.USD","LU1917777945.USD","LU1093756168.USD","LU2063271972.USD","AGNG","LU0114720955.EUR","LU1057294990.SGD","LU1720051017.SGD","LU1868836757.USD","IE00B4R5TH58.HKD","GDOC","LU0385154629.USD","IE00B1BXHZ80.USD","LU0210536198.USD","LU1061106388.HKD","LU1127390331.HKD","SG9999015952.SGD","IE00BK4W5L77.USD","IE0005OL40V9.USD","LU0786609619.USD","LU2112291526.USD","LU2236285917.USD","IE00BN29S564.USD","SGXZ51526630.SGD","SG9999015945.SGD","IE00BK4W5M84.HKD","LU0079474960.USD","SGXZ31699556.SGD","LU1691799644.USD","IE00BJJMRX11.SGD","LU0354030511.USD","LU0158827781.USD","LU0823434740.USD","LU0964807845.USD","LU1064131342.USD","BMRN","LU0238689110.USD","IE00BJJMRY28.SGD","LU0266013472.USD","LU1069344957.HKD","LU2168564065.EUR","LU2213496289.HKD","LU2237438978.USD","LU2237443465.HKD","LLII","PTH","LU2360106947.USD","LU2237443622.USD","LU0058720904.USD","BK4007","LU0471298694.HKD","LU2089283258.USD","IE00B4JS1V06.HKD","LU1145028129.USD","LU2746668461.USD","LU0820562030.AUD","SGXZ57979304.SGD","LU1323610961.USD","LU1868836591.USD","LU2357305700.SGD","IYH","LU0345770308.USD","IE0004445239.USD","LU2324357040.USD","LU0203202063.USD","LU2552382058.USD","LU2089984988.USD","LU0417517546.SGD","LU2023250330.USD","LU0354030438.USD","LU0320765059.SGD","LU1551013342.USD","LU1623119135.USD","LU0109391861.USD","AXSM","IE00BJJMRZ35.SGD","LU2552382132.HKD","LU0289739699.SGD","LU0882574055.USD","SGXZ81514606.USD","IE00B1XK9C88.USD","SG9999018865.SGD","ELIL","IE0001KFT4U8.USD","IE00BWXC8680.SGD","LU1548497426.USD","LU2237443978.SGD","PJP","IE00BKDWB100.SGD","HRTS","LU2462591350.SGD","LU2462157665.USD","IE00BJT1NW94.SGD","LU1280957306.USD","LU1988902786.USD","LU1979441026.SGD","LU0787776722.HKD","LU2168563687.JPY","LU0882574139.USD","LU2237443895.HKD","IHE","RXL","IE00BFSS8Q28.SGD","IE00BJLML261.HKD","LU0106261372.USD","IE00BKPKM429.USD","LLYZ","LU1868836914.USD","SG9999015986.USD","LU0320765992.SGD","GB00BDT5M118.USD","LU1712237335.SGD","LU2265009873.SGD","LU2271345857.HKD","LU0122379950.USD","LU0672654240.SGD","SG9999014906.USD","LU2746668974.SGD","OZEM","LU0061475181.USD","LU0820561909.HKD","LU0225283273.USD","IXJ","LU0708995401.HKD","LU2089284900.SGD","LU1232071149.USD","JDOC","BK4534","BK4533","LU0198837287.USD","LU2750360997.AUD","THNR","LU0234572021.USD","LU1291159041.SGD","SG9999014898.SGD","LU2106854487.HKD","LU0323591593.USD","LU2211815571.USD","LU2168564222.USD","LU1629891620.HKD","LU2108987350.USD","SG9999001176.USD","LU0316494557.USD","IE00B19Z3B42.SGD","LU0094547139.USD","ELIS","LU2471134796.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668394404","title":"All 50 States Sign up for Trump's Medicaid Most-Favored-Nation Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2668394404","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668394404?lang=en_us&edition=fundamental","pubTime":"2026-09-18 17:46","pubTimestamp":1789724814,"startTime":"0","endTime":"0","summary":"UPDATE 4-All 50 states sign up for Trump's Medicaid most-favored-nation planSept 18 (Reuters)-US President Donald Trump said on Friday that all 50 states, the District of Columbia and Puerto Rico will","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL1N45A0B2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2168564065.EUR","LU1291159041.SGD","SG9999002224.SGD","WDNA","BK4588","LLY","THNR","PFE","LU0256863902.USD","BK4585","LU0225283273.USD","LU2063271972.USD","HRTS","ELIS","IHE","XLV","GDOC","LLII","LU1868836591.USD","FTXH","IXJ","CURE","ELIL","IYH","LLYX","LU0094547139.USD","LU2265009873.SGD","PJP","LU1989771016.USD","AGNG","MHIP","LLYZ","MEDX","TRUH","LU1267930730.SGD","LU0345770993.USD","CANC","MEDI","JDOC","LU2471134523.USD","LU0234572021.USD","OZEM","TMED","LU1720051017.SGD","PPH","RXL","SGXZ51526630.SGD","VHT","ILDR","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668941012","title":"Sandoz Faces Uncertain Opportunity with New Drug Approval in Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2668941012","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668941012?lang=en_us&edition=fundamental","pubTime":"2026-09-18 17:18","pubTimestamp":1789723080,"startTime":"0","endTime":"0","summary":"0918 GMT - Sandoz Group's approval for a generic version of Novo Nordisk's Ozempic in Canada is positive, but it is difficult to assess how big of a boost this will be for the Swiss generic-drug manufacturer, RBC Capital Markets' Harry Sephton says. \"The overall generic opportunity is uncertain given we expect Novo to compete on price and it likely has the lowest cost of production, additionally it has shown willingness to compete in Canada with the launch of its own authorized generics Plosbrio and Poviztra,\" the analyst says in a research note. The Canadian market is large, with the Ozempic market estimated at around $1 billion and the total GLP-1 market at $2.6 billion, RBC says. Sandoz shares rise 2.7%.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","IE00BKVL7J92.USD","NVOX","BK4585","NVOH","SDZXF","NVO","LU0154236417.USD","LU1093756325.SGD","BK4007","IE00BZ1G4Q59.USD","BK4588","BK4532","NVOC","THNR","PPH","OZEM","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668949215","title":"Sandoz Receives Marketing Authorization for Generic Version of Ozempic in Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2668949215","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668949215?lang=en_us&edition=fundamental","pubTime":"2026-09-18 16:45","pubTimestamp":1789721117,"startTime":"0","endTime":"0","summary":"Sandoz has received Health Canada's marketing authorization for its Semaglutide product, which is a generic version of Novo Nordisk's  Ozempic, according to a Friday statement.The approval expands patient access to semaglutide treatment in Canada, Sandoz said.Sandoz said the weekly injection is approved for adults with type 2 diabetes and will be offered in three strengths across two pen devices.According to the company, the US Food and Drug Administration has also recently accepted its application for the in-house development of generic tirzepatide, and the Owozy semaglutide product, for which it holds commercial rights, has been approved in Brazil.Sandoz said the approval will not alter its 2026 financial outlook, with no meaningful contribution from generic semaglutide expected this year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PPH","SDZNY","IE00BZ1G4Q59.USD","BK4585","NVOC","THNR","NVO","LU1093756168.USD","BK4588","NVOH","BK4532","IE00BKVL7J92.USD","BK4599","OZEM","BK4007","NVOX","LU0154236417.USD","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668915626","title":"When Weight Loss Isn't the Goal of Taking a GLP-1","url":"https://stock-news.laohu8.com/highlight/detail?id=2668915626","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668915626?lang=en_us&edition=fundamental","pubTime":"2026-09-18 09:00","pubTimestamp":1789693200,"startTime":"0","endTime":"0","summary":"At 5 feet 11 inches and 138 pounds, Ali Balkey has always been thin.So it might seem surprising that the 41-year-old Dallas, Texas real-estate investor says she has been taking a compounded version of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","LU0432979614.USD","LU0345770993.USD","LU0683600562.USD","SG9999014880.SGD","IE00BJJMRX11.SGD","LU0289739699.SGD","LU2023251221.USD","LU2236285917.USD","LU2746668461.USD","LU2112291526.USD","LU0094547139.USD","LU1548497426.USD","LU2089284900.SGD","TRUH","LU2237443895.HKD","LU2168564065.EUR","LU2552382215.SGD","MEDX","LU0345770308.USD","LU1145028129.USD","IE00BJLML261.HKD","LU0133085943.USD","LU1720051017.SGD","GDOC","WDNA","SGXZ57979304.SGD","LU0154236417.USD","IE0005OL40V9.USD","IE0002141913.USD","LU0238689110.USD","LLY","LU2360106947.USD","LU2324357040.USD","LU1064131342.USD","BK4516","SG9999018857.SGD","LU0320765992.SGD","LU0672654240.SGD","LU0787776722.HKD","LU0203202063.USD","IE00BKVL7J92.USD","LLYX","LU0234572021.USD","FTXH","LU0466842654.USD","LU0006306889.USD","HRTS","IYH","LU0061475181.USD","LU0256863902.USD","IE00BN29S564.USD","LU0708995401.HKD","LU1232071149.USD","LU2211815571.USD","LU2491050154.USD","SG9999001176.SGD","LU0266013472.USD","LU2265009873.SGD","IE00BJT1NW94.SGD","LU2237438978.USD","LU1983299246.USD","IE0004445015.USD","LU2750360997.AUD","IE00BFSS7M15.SGD","LU0096364046.USD","LU2237443549.SGD","LU0097036916.USD","GB00BDT5M118.USD","LU0198837287.USD","SG9999014898.SGD","LU0323591593.USD","LU2168564149.EUR","AGNG","BK4588","LU2361044865.SGD","IE00BJJMRZ35.SGD","LU2471134796.USD","OZEM","LU2213496289.HKD","LU2746668974.SGD","LU0820561818.USD","IHE","LU0316494557.USD","LU2417539215.USD","LU0158827948.USD","LU0353189680.USD","LU0385154629.USD","LU1280957306.USD","LU2237443622.USD","LU2456880835.USD","LU2168564495.EUR","LU1023059063.AUD","LU2361044949.HKD","NVO","IE0009355771.USD","IE00BZ1G4Q59.USD","IE00B775H168.HKD","LU1323610961.USD","LU2089283258.USD","LU1868836757.USD","LU0353189763.USD","LU0122379950.USD","LU0210536198.USD","IE00BK4W5M84.HKD","LU2552382058.USD","LU2087625088.SGD","NVOC","IE00BK4W5L77.USD","LU0882574139.USD","SG9999015986.USD","ELIL","LU2028103732.USD","IE00BKDWB100.SGD","LU1691799644.USD","IE00B7KXQ091.USD","IE00BFTCPJ56.SGD","LU0456855351.SGD","LU0820562030.AUD","LU0203201768.USD","LU1127390331.HKD","XLV","IE0001KFT4U8.USD","LU0943347566.SGD","LU2471134879.HKD","LU0417517546.SGD","LU1629891620.HKD","LU2089984988.USD","NVOX","LU2468319806.SGD","LU2750360641.GBP","LU1814569148.SGD","LU0320765059.SGD","LU2462591350.SGD","LU0823416689.USD","LU1712237335.SGD","LU2461242641.AUD","SG9999013999.USD","LU0354030511.USD","LU2108987350.USD","SG9999015952.SGD","LU0823434583.USD","IE00B4JS1V06.HKD","LU1551013342.USD","LU2237443465.HKD","LU1291159041.SGD","LU0823434740.USD","LU1917777945.USD","SGXZ81514606.USD","LU1868837300.USD","LU1720051108.HKD","SG9999017495.SGD","LU1989771016.USD","SGXZ51526630.SGD","LU1093756168.USD","LU0106261372.USD","ILDR","LU0109394709.USD","LU1057294990.SGD","SG9999014906.USD","LU1035775433.USD","LU0471298777.SGD","LU2111349929.HKD","LU1061106388.HKD","LU1623119135.USD","LU2602419157.SGD","FHLC","LU2106854487.HKD","BK4534","MEDI","THNR","LU1093756325.SGD","LU0889565916.HKD","LU1267930730.SGD","BK4599","LU2462157665.USD","LU1868836914.USD","VHT","BK4533","IE00B1BXHZ80.USD","LU2552382132.HKD","TMED","LU0079474960.USD","LU0354030438.USD","LU1979441026.SGD","LU2361045086.USD","MHIP","SG9999014914.USD","LU2471134952.CNY","BK4007","LU2023250330.USD","LU2357305700.SGD","SG9999001176.USD","LU2168563687.JPY","IE00B1XK9C88.USD","IE00BFSS8Q28.SGD","LLYZ","LU2756315664.SGD","SGXZ31699556.SGD","IE00BJJMRY28.SGD","LU2271345857.HKD","LU2237443978.SGD","LU0114720955.EUR","SG9999015978.USD","RXL","LU0225283273.USD","LU0882574055.USD","LU0471298694.HKD","IE00B2B36J28.USD","LU1551013425.SGD","LU2896262040.SGD","PJP","BK4585","LU2168564222.USD","ELIS","PPH","IE00BWXC8680.SGD","LU2264538146.SGD","LU1804176565.USD","LU0256863811.USD","IE00B4R5TH58.HKD","LU1069344957.HKD","CANC","LU0058720904.USD","LU0820561909.HKD","LU1868836591.USD","LU2491050071.SGD","IXJ","SGXZ99366536.SGD","LU2471134523.USD","NVOH","IE0004445239.USD","LU1974910355.USD","LU1988902786.USD","SG9999015945.SGD","LU1366192091.USD","LU0786609619.USD","LU2491049909.HKD","BK4532","LLII","LU2063271972.USD","CURE","IE00BKPKM429.USD","LU0174119429.USD","LU0689472784.USD","LU0964807845.USD","LU1868837136.USD","LU2756315318.SGD","SG9999018865.SGD","LU0109391861.USD","LU0640476718.USD","LU2237443382.USD","LU0158827781.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668960992","title":"Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2668960992","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668960992?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:31","pubTimestamp":1789677060,"startTime":"0","endTime":"0","summary":"DJ Eli Lilly & Co. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Eli Lilly & Co.  rallied 1.28% to $1,152.44 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 1.14% to 7,637.76 and the Dow Jones Industrial Average  rising 0.61% to 51,778.04.This was the stock's second consecutive day of gains.Eli Lilly & Co. closed 10.85% short of its 52-week high of $1,292.65, which the company achieved on August 19th.The stock outperformed some of its competitors Thursday, as Johnson & Johnson  rose 1.10% to $270.22, Pfizer Inc.  rose 0.66% to $27.64, and AbbVie Inc.  rose 0.58% to $264.02.Trading volume  remained 629,541 below its 50-day average volume of 2.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 17, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MHIP","LU2361045086.USD","IE00B4JS1V06.HKD","PJP","LU0943347566.SGD","LU0079474960.USD","LU0820561818.USD","LU1623119135.USD","BK4533","PPH","LU0203201768.USD","LU0133085943.USD","LU2746668461.USD","SG9999018865.SGD","IE00B2B36J28.USD","LU2552382215.SGD","LU1979441026.SGD","FTXH","LU1917777945.USD","IYH","LU1127390331.HKD","LU1057294990.SGD","LU2168564495.EUR","LU0158827948.USD","WDNA","LU1974910355.USD","LU0198837287.USD","BK4585","BK4534","IE00BJJMRX11.SGD","BK4581","CURE","LU0203202063.USD","MEDX","SG9999014906.USD","LU1691799644.USD","LU2756315664.SGD","THNR","LU0109394709.USD","LU2106854487.HKD","IE00BK4W5M84.HKD","LU0094547139.USD","LU1093756168.USD","LU0823434740.USD","LU0882574055.USD","LU1548497426.USD","LU0096364046.USD","LU1804176565.USD","TRUH","LU0210536198.USD","IE00BKDWB100.SGD","LU2023250330.USD","LU2028103732.USD","LU0471298777.SGD","SG9999014898.SGD","LU2456880835.USD","LU2237443895.HKD","IE0002141913.USD","LU0238689110.USD","BK4599","LU0787776722.HKD","LU2491050071.SGD","BK4007","LU0354030438.USD","LU1814569148.SGD","LU0640476718.USD","SG9999015952.SGD","LU0672654240.SGD","SG9999014914.USD","SGXZ81514606.USD","LU2168564065.EUR","LU1551013425.SGD","LU0006306889.USD","LU1868836591.USD","LLYX","LU0889565916.HKD","LU1061106388.HKD","LU1280957306.USD","LU1629891620.HKD","SG9999018857.SGD","LLII","LU0122379950.USD","IE00B1XK9C88.USD","LU0234572021.USD","LU0256863811.USD","LU0323591593.USD","LU0345770308.USD","LU2417539215.USD","LU2237443978.SGD","LU2471134523.USD","LU2264538146.SGD","IHE","VHT","LU2063271972.USD","LU2237438978.USD","LLY","LU1093756325.SGD","LU2896262040.SGD","LU1720051017.SGD","LU0432979614.USD","LU2237443549.SGD","LU2471134796.USD","IE00BFTCPJ56.SGD","LU2552382058.USD","LU0225283273.USD","SG9999013999.USD","LU0158827781.USD","SG9999015945.SGD","LU2089284900.SGD","LU0689472784.USD","LU2023250504.SGD","IE00B4R5TH58.HKD","LU2471134952.CNY","LU2087625088.SGD","LU0820561909.HKD","XLV","LU1232071149.USD","LU2471134879.HKD","LU0823434583.USD","IE0004445239.USD","LU0964807845.USD","LU0320765059.SGD","LU1868837300.USD","LU2108987350.USD","LU2213496289.HKD","LU2237443622.USD","LU1366192091.USD","ELIS","LU1983299246.USD","LU0466842654.USD","LU0097036916.USD","FHLC","IE00BFSS7M15.SGD","LU2357305700.SGD","IE0005OL40V9.USD","IE0004445015.USD","LU2750360997.AUD","LU0316494557.USD","LU2360106947.USD","SGXZ51526630.SGD","LU2089984988.USD","LU2361044949.HKD","LU0385154629.USD","LU1291159041.SGD","LU0345770993.USD","RXL","TMED","LLYZ","IE00B775H168.HKD","LU0058720904.USD","SG9999001176.SGD","IE00BK4W5L77.USD","LU1323610961.USD","SG9999001176.USD","IE00BJT1NW94.SGD","LU2265009873.SGD","LU1064131342.USD","LU0353189763.USD","LU2211815571.USD","SGXZ99366536.SGD","IE00BJLML261.HKD","LU0683600562.USD","IE0001KFT4U8.USD","SG9999015978.USD","GDOC","HRTS","IXJ","LU1720051108.HKD","LU0820562030.AUD","SG9999017495.SGD","SG9999014880.SGD","LU2168563687.JPY","LU2552382132.HKD","LU2271345857.HKD","IE00BJJMRY28.SGD","MEDI","BK4516","LU1988902786.USD","LU0109391861.USD","LU1145028129.USD","GB00BDT5M118.USD","IE00BWXC8680.SGD","LU0174119429.USD","LU0823416689.USD","LU2461242641.AUD","LU0114720955.EUR","LU0456855351.SGD","LU0061475181.USD","LU1551013342.USD","LU2168564222.USD","BK4588","LU1868836914.USD","SGXZ57979304.SGD","LU2237443465.HKD","IE00B1BXHZ80.USD","LU0266013472.USD","ILDR","LU1267930730.SGD","LU0471298694.HKD","LU0106261372.USD","LU0882574139.USD","LU2746668974.SGD","LU2168564149.EUR","IE00BFSS8Q28.SGD","AGNG","LU2491049909.HKD","LU1069344957.HKD","LU2468319806.SGD","LU1712237335.SGD","LU2236285917.USD","LU2237443382.USD","LU2361044865.SGD","SG9999015986.USD","LU0320765992.SGD","LU2089283258.USD","LU0289739699.SGD","LU0708995401.HKD","LU0786609619.USD","LU1868837136.USD","ELIL","LU0353189680.USD","LU2111349929.HKD","LU2491050154.USD","LU1989771016.USD","LU1023059063.AUD","LU0354030511.USD","LU2462157665.USD","CANC","LU2602419157.SGD","SGXZ31699556.SGD","IE00B7KXQ091.USD","IE00BKPKM429.USD","OZEM","LU2750360641.GBP","IE00BJJMRZ35.SGD","LU1035775433.USD","JDOC","LU2462591350.SGD","IE00BN29S564.USD","LU2023251221.USD","LU1868836757.USD","LU0417517546.SGD","LU2324357040.USD","LU2112291526.USD","LU2756315318.SGD","LU0256863902.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668999234","title":"Hims & Hers CTO Mohamed Elshenawy Sells 7,954 Shares Worth $225,421.06","url":"https://stock-news.laohu8.com/highlight/detail?id=2668999234","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668999234?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:18","pubTimestamp":1789676306,"startTime":"0","endTime":"0","summary":"Hims & Hers CTO Mohamed Elshenawy sells 7,954 shares worth $225,421.06Mohamed Elshenawy, CTO, sold 7,954 shares of Class A common stock on Sept. 15, 2026 at $28.39.Post-transaction holding stood at 18","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL49p1vR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Hims & Hers CTO Mohamed Elshenawy Sells 7,954 Shares Worth $225,421.06","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMC","HIMY","HIMS","GLAM","HMYY","BK4196","HIMZ","THNR","HEAL","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668999182","title":"Novo Nordisk Wins EMA Panel Backing for New Haemophilia A Therapy FREHEMGO","url":"https://stock-news.laohu8.com/highlight/detail?id=2668999182","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668999182?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:57","pubTimestamp":1789664236,"startTime":"0","endTime":"0","summary":"Novo Nordisk ( ($NVO) ) has issued an announcement. Novo Nordisk announced on 17 September 2026 that the European Medicines Agency’s Committee for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-wins-ema-panel-backing-for-new-haemophilia-a-therapy-frehemgo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-wins-ema-panel-backing-for-new-haemophilia-a-therapy-frehemgo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["THNR","BK4585","OZEM","BK4588","BK4599","LU1093756168.USD","NVOH","LU1093756325.SGD","BK4007","BK4532","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0154236417.USD","NVO","NVOC","NVOX","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668999582","title":"Novo Nordisk A/S Stock (NVO) Moved Up by 3.02% on Sep 17: What Signal Does It Send?","url":"https://stock-news.laohu8.com/highlight/detail?id=2668999582","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668999582?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:15","pubTimestamp":1789661722,"startTime":"0","endTime":"0","summary":"• Novo Nordisk partnered with Orbis Medicine for AI-driven oral cardiometabolic drug discovery.\n• European regulators issued a favorable marketing recommendation for Frehemgo in hemophilia A.\n• The company reported $46.70B in annual revenue and $15.48B in net profit.","market":"hk","thumbnail":"https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262173629-market-movers-nvo-20260917","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4007","BK4588","NVOH","NVOX","NVOC","BK4585","OZEM","PPH","THNR","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","LU1093756168.USD","LU0154236417.USD","IE00BKVL7J92.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668201995","title":"Cboe data suggests bullish flow in Novo Nordisk with shares up 3.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668201995","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668201995?lang=en_us&edition=fundamental","pubTime":"2026-09-17 23:40","pubTimestamp":1789659620,"startTime":"0","endTime":"0","summary":"Cboe data suggests bullish flow in Novo Nordisk (NVO), with shares up $1.38, or 3.3%, near $43.09. Options volume running well above average with 3...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-novo-nordisk-with-shares-up-3-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-novo-nordisk-with-shares-up-3-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","NVOH","NVOX","LU1093756325.SGD","LU1093756168.USD","OZEM","BK4588","THNR","BK4007","LU0154236417.USD","NVO","BK4585","PPH","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4599","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668745993","title":"Novo Nordisk's Frehemgo to Treat Haemophilia A Receives CHMP Recommendation for EU Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2668745993","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668745993?lang=en_us&edition=fundamental","pubTime":"2026-09-17 22:57","pubTimestamp":1789657021,"startTime":"0","endTime":"0","summary":"Novo Nordisk  said Thursday that the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended marketing authorization for Frehemgo or denecimig in the European Union to treat haemophilia A, a bleeding disorder.CHMP's positive opinion is based on the company's trial data that showed denecimig reduced annualised bleeding rate compared with prior clotting factor prophylaxis and on-demand treatment in patients, according to a statement.The company said it expects to launch Frehemgo in European countries from Q4 onwards.Price: 42.88, Change: +1.17, Percent Change: +2.79","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PPH","LU1093756168.USD","BK4599","LU0154236417.USD","THNR","IE00BKVL7J92.USD","NVOC","BK4588","BK4007","NVOH","LU1093756325.SGD","BK4585","BK4532","NVOX","NVO","IE00BZ1G4Q59.USD","OZEM"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}